Sildenafil for primary and secondary pulmonary hypertension

Clinical Pharmacology and Therapeutics

Volumn 71, Issue 5, 2002, Pages 398-402

  Watanabe, Hiroshi ^a   Ohashi, Kyoichi ^a   Takeuchi, Kazuhiko ^a   Yamashita, Kazuhiro ^a   Yokoyama, Taku ^a   Tran, Quang Kim ^a   Satoh, Hiroshi ^a   Terada, Hajime ^a   Ohashi, Hiroyuki ^a   Hayashi, Hideharu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; COLLAGEN DISEASE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EXERCISE; FEMALE; HEART CATHETERIZATION; HEART INDEX; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; QUALITY OF LIFE; SIDE EFFECT; VASODILATATION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADULT; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; PIPERAZINES; PULMONARY WEDGE PRESSURE; TIME; VASODILATOR AGENTS;

EID: 18344392448     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2002.123554     Document Type: Article

References (8)

1. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors
2. Erectile dysfunction
3. Viagra for impotence of pulmonary vasodilator therapy?
4. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension
5. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal
6. Sildenafil in primary pulmonary hypertension
7. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
8. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man